임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
7건 표시
- 1/2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
- 1/2상모집 중· Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
협력: 얀센(J&J)
- 1/2상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
리드: 얀센(J&J)
- 1/2상모집 중· HIV InfectionsPharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
협력: 얀센(J&J)
- 1/2상모집 중· Advanced or Metastatic Colorectal CancerA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
리드: 얀센(J&J)
- 1/2상모집 중· Non-Muscle Invasive Bladder NeoplasmsStudy of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
리드: 얀센(J&J)
- 1/2상모집 중· Acute LeukemiaA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
리드: 얀센(J&J)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.